Kyverna Therapeutics, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €930.35K
    Gross profit
    -€444.46K
    SG&A expenses
    €30.81M
    R&D expenses
    €117.31M
    EBITDA
    -€140.35M
    D&A
    €967.46K
    EBIT
    -€148.12M
    Interest expenses
    €41.43K
    EBT
    -€136.96M
    Tax expenses
    €0.00
    Net income
    -€136.96M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €144.13K
    Changes in working capital
    €7.29M
    Operating cash flow
    -€122.05M
    Capex
    €547.16K
    Other investing cash flow
    €6.33M
    Net investing cash flow
    €55.79M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €287.39K
    Debt repayment
    -€648.14K
    Other financing cash flow
    -€586.00K
    Net financing cash flow
    -€1.23M
    Foreign exchange effects
    €0.00
    Net change in cash
    -€67.49M
    Cash at end of period
    €46.60M
    Free cash flow
    -€121.50M

    Balance sheet

    Cash and cash equivalents
    €46.12M
    Cash and short-term investments
    €182.68M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €2.29M
    Total current assets
    €184.97M
    Property, plant & equipment
    €6.54M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €475.53K
    Other non-current assets
    €3.50M
    Total non-current assets
    €10.51M
    Total assets
    €195.48M
    Accounts payable
    €8.56M
    Short-term debt
    €3.09M
    Other current liabilities
    €22.69M
    Total current liabilities
    €34.34M
    Long-term debt
    €4.04M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €2.02M
    Total liabilities
    €36.36M
    Common stock
    €0.00
    Retained earnings
    -€302.27M
    Other equity
    -€17.26K
    Total equity
    €159.12M
    Total liabilities and shareholders' equity
    €195.48M

    Company information

    Market capitalization
    €120.91M
    Employees
    112
    Enterprise Value
    €93.13M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -86.1%
    ROA
    -70.1%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -101.4%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€1.22M

    Notifications